Q32 Bio Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Q32 Bio Inc. has filed 549 SEC EDGAR filings since 06 Jan 2016

SEC filing history

Showing 376-400 of 549 matching filings.

Per page
25
Current page
16
S-3ASR File 333-237131

S-3ASR

Filing date
12 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90433

SC 13G/A

Filing date
10 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90433

SC 13G/A filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90433

SC 13G filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90433

ARCH VENTURE FUND VIII, L.P. - HOMOLOGY MEDICINES, INC. -- SCHEDULE 13G/A(#1)

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90433

SC 13G/A filing

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90433

SC 13G/A

Filing date
06 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90433

SC 13D/A filing

Filing date
31 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2020
Reporting date
29 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jan 2020
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jan 2020
Reporting date
24 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90433

FILING HOMOLOGY MEDICINES, INC.

Filing date
15 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2020
Reporting date
02 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90433

SC 13G filing

Filing date
30 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90433

SC 13D/A filing

Filing date
30 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Dec 2019
Reporting date
24 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Dec 2019
Reporting date
19 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38433

8-K

Filing date
19 Dec 2019
Reporting date
17 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Dec 2019
Reporting date
11 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Dec 2019
Reporting date
11 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .